Guru Ownership Trend
Guru Analysis for Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S (ASND), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $30.29 M.
Top institutional holders include Renaissance Technologies (RenTech) and John Hussman.
Institutional sentiment is currently Bullish. This is evidenced by a $2.46 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Ascendis Pharma A/S (ASND)
Major holders include Renaissance Technologies (RenTech) ($26.84 M), John Hussman ($1.92 M), Cliff Asness ($351,558). According to the latest reported data, 3 tracked investment managers collectively hold approximately 127,269 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.46 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited ASND. The total reported sell value was $26.66 M.
Yes, 3 managers opened new positions in ASND, and 0 increased their existing holdings. The total reported buy value was $29.11 M.